Wire Stories
-
434Chinese Dental Equipment and Supplies Markets Report 2022: China’s Demand for Dental Equipment and Supplies Will Continue to Grow at 6% by 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dental Equipment and Supplies Markets in China” report has been added to ResearchAndMarkets.com’s offering. China’s demand for Dental Equipment and...
-
446Chinese Health Care Markets Report 2022: Demand for Health Care will continue to grow at about 11% by 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Health Care Markets in China” report has been added to ResearchAndMarkets.com’s offering. Focus on China’s Healthcare for 1.3 Billion People...
-
447
Chinese Health Care Markets Report 2022: Demand for Health Care will continue to grow at about 11% by 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Health Care Markets in China” report has been added to ResearchAndMarkets.com’s offering. Focus on China’s Healthcare for 1.3 Billion People...
-
485CTBA Chairman Jeffrey Koo, Jr. to Serve as WBSC Executive Vice President, BFA President
TAIPEI,Taiwan–(BUSINESS WIRE)–The closing ceremony of the 4th World Baseball Softball Confederation (WBSC) and Baseball Federation of Asia (BFA) Congress took place on...
-
487The 2021 Annual International Forum on Higher Education Was Held at Sun Yat-sen University
BEIJING–(BUSINESS WIRE)–On June 26, the 2021 Annual International Forum on Higher Education, was held at Sun Yat-sen University in Guangzhou both online...
-
490Green Tiger Markets Pte. Ltd. Arranges the First Trade of GTM’s Physically Settled Bilateral Rhodium Contract
SINGAPORE–(BUSINESS WIRE)–Green Tiger Markets Pte. Ltd. (GTM) is excited to announce the first trade in Physical Rhodium on its cloud-based trading platform....
-
502
Element Materials Technology Announces Completion of its Acquisition by Temasek
LONDON–(BUSINESS WIRE)–Element Materials Technology (Element), a global leader in testing, inspection, and certification (TIC) services, has completed its acquisition by Temasek, a...
-
489
�InnoCare Announces Approval of Clinical Trial of Novel Targeted Protein Degrader ICP-490 in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the...
-
519CANbridge Forms Scientific Advisory Board to Guide Global Development of CAN106 in Complement-mediated Diseases
CAN106 Phase 1 results showed rapid and potent C5 inhibition, complete and sustained blockade of complement activity Data presented at European Hematology...
-
477Slingshot Biosciences, Inc. Partners With Chameleon Science to Distribute Synthetic Cells Throughout Australia, New Zealand & Singapore
EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC., the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement...
